Facebook Instagram LinkedIn
YoungMD Connect Eyewire+ Eyetube Podcasts
RT Header Logo
Search

Search Results

Show Filters

Refine By Year

View More +

Sort By:

Relevance Date

Relevance

Date

November/December 2023 Supplement

Advances in treatment of dry AMD and geographic atrophy

Anat Loewenstein; Frank Holz; Patricia Udaondo; Adnan Tufail; Stela Vujosevic; and Peter Kaiser

November/December 2023 Supplement

Management of dry AMD and geographic atrophy

Anat Loewenstein; Frank Holz; Patricia Udaondo; Adnan Tufail; Stela Vujosevic; and Peter Kaiser

November/December 2023 Supplement

Risk factors and demographics of AMD and geographic atrophy

Anat Loewenstein; Frank Holz; Patricia Udaondo; Adnan Tufail; Stela Vujosevic; and Peter Kaiser

October 2022 | Meeting Minutes

A Peek at The Clinical Trials at the Summit

The latest research was on display at the 2nd annual CTS meeting at Lake Tahoe, Nevada.

Aamir A. Aziz, MSII

March 2022

Looking to the Future: Gene Therapy in AMD & DME

Doctor Carl C Awh MD, FASRS; Professor Dr.med Frank G Holz FEBO, FARVO; Professor Dr Antonia Joussen MD; Professor Anat Loewenstein MD, MHA; and Doctor Nancy M Holekamp MD

March 2022

Improving Treatment Adherence & Treatment Outcomes

Doctor Carl C Awh MD, FASRS; Professor Dr.med Frank G Holz FEBO, FARVO; Professor Dr Antonia Joussen MD; Professor Anat Loewenstein MD, MHA; and Doctor Nancy M Holekamp MD

March 2022

Key Drivers of Poor Adherence to AMD & DME Treatment

Doctor Carl C Awh MD, FASRS; Professor Dr.med Frank G Holz FEBO, FARVO; Professor Dr Antonia Joussen MD; Professor Anat Loewenstein MD, MHA; and Doctor Nancy M Holekamp MD

March 2022

Management of AMD & DME: Treatment Switching in Patients with Suboptimal Treatment Response

Carl Awh MD, FASRS; Professor Dr.med Frank G Holz FEBO, FARVO; Professor Dr Antonia Joussen MD; Professor Anat Loewenstein MD, MHA; and Doctor Nancy M Holekamp MD

March 2022

Management of AMD & DME: Goals of Modern Treatment Strategy

Doctor Carl C Awh MD, FASRS; Professor Dr.med Frank G Holz FEBO, FARVO; Professor Dr Antonia Joussen MD; Professor Anat Loewenstein MD, MHA; and Doctor Nancy M Holekamp MD

March 2022

Innovations in the Diagnosis & Monitoring of AMD & DME

Doctor Carl C Awh MD, FASRS; Professor Dr.med Frank G Holz FEBO, FARVO; Professor Dr Antonia Joussen MD; Professor Anat Loewenstein MD, MHA; and Doctor Nancy M Holekamp MD

March 2022

Introduction

Doctor Carl C Awh MD, FASRS; Professor Dr.med Frank G Holz FEBO, FARVO; Professor Dr Antonia Joussen MD; Professor Anat Loewenstein MD, MHA; and Doctor Nancy M Holekamp MD

March 2022 Supplement

Considerations on the Management of Macular Neovascularization in Patients with Geographic Atrophy Enrolled in Clinical Trials

Lead Author: Peter K. Kaiser, MD
Co-Authors: Glenn J. Jaffe, MD; Frank G. Holz, MD, FEBO; Jeffrey S. Heier, MD; SriniVas R. Sadda, MD; and Arshad M. Khanani, MD, MA

September 2010

Type 2 Ideopathic Macular Telangiectasia

Frank G. Holz, MD

May/June 2010 | Retinal Imaging Feature

Imaging and Pharmacologic Approaches in the Treatment of Geographic Atrophy in AMD

Imaging with FAF offers new insight into how and why GA progresses in some patients.

Frank G. Holz, MD

May/June 2010 | Retinal Imaging Feature

Imaging and Pharmacologic Approaches in the Treatment of Geographic Atrophy in AMD

Imaging with FAF offers new insight into how and why GA progresses in some patients.

Frank G. Holz, MD

January/February 2010 Supplement

Type 2 Ideopathic Macular Telangiectasia

Frank G. Holz, MD

April 2009

Autofluorescence Imaging

Clinical application with SD OCT imaging.

Frank G. Holz, MD

VIEW MORE

Ad Close Image